Results 121 to 130 of about 1,816 (169)

Mixed HCV Infection of Genotype 1B and Other Genotypes Influences Non-response during Daclatasvir + Asunaprevir Combination Therapy

open access: yes
Daclatasvir (DCV) + asunaprevir (ASV) combination therapy has become available for patients with hepatitis C virus (HCV) serogroup 1 infection. We studied the efficacy of this therapy by focusing on the factors associated with sustained virological ...
Sakaguchi, Kosaku   +20 more
core  

Hepatitis C Virus Resistance-Associated Substitutions in Mexico. [PDF]

open access: yesViruses
Jose-Abrego A   +4 more
europepmc   +1 more source

Rarely listed essential medicines in 158 national lists. [PDF]

open access: yesJ Pharm Policy Pract
Ul Haq MZ   +4 more
europepmc   +1 more source

Using Organs from Hepatitis C-Infected Donors: A Cautionary Experience. [PDF]

open access: yesTransplant Direct
Shanahan E   +3 more
europepmc   +1 more source

Cell-Based Luciferase Assay for Testing SARS-CoV-2 3CL Protease Inhibitors. [PDF]

open access: yesBiosensors (Basel)
Shcherbakov DN   +9 more
europepmc   +1 more source

Unveiling the nexus between direct-acting antivirals in hepatitis C virus elimination and immune response. [PDF]

open access: yesClin Exp Med
Abdelaziz AI   +5 more
europepmc   +1 more source

Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan. [PDF]

open access: yesClin Mol Hepatol
Huang CF   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy